These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34650958)

  • 21. Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.
    Hameed NS; Arif IS; Al-Sudani BT
    J Adv Pharm Technol Res; 2023; 14(3):185-190. PubMed ID: 37692001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.
    Bouback TA; Pokhrel S; Albeshri A; Aljohani AM; Samad A; Alam R; Hossen MS; Al-Ghamdi K; Talukder MEK; Ahammad F; Qadri I; Simal-Gandara J
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
    Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
    Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery.
    Arunkumar M; Gunaseelan S; Kubendran Aravind M; Mohankumar V; Anupam P; Harikrishnan M; Siva A; Ashokkumar B; Varalakshmi P
    J Biomol Struct Dyn; 2022; 40(19):8961-8988. PubMed ID: 34014150
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
    Shah M; Yamin R; Ahmad I; Wu G; Jahangir Z; Shamim A; Nawaz H; Nishan U; Ullah R; Ali EA; Sheheryar ; Chen K
    PLoS One; 2024; 19(1):e0294769. PubMed ID: 38175855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 30. In Vitro and In Silico Studies for the Identification of Potent Metabolites of Some High-Altitude Medicinal Plants from Nepal Inhibiting SARS-CoV-2 Spike Protein.
    Basnet S; Marahatha R; Shrestha A; Bhattarai S; Katuwal S; Sharma KR; Marasini BP; Dahal SR; Basnyat RC; Patching SG; Parajuli N
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
    Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
    PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
    Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
    Front Immunol; 2021; 12():613045. PubMed ID: 33841395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19.
    Tariq A; Mateen RM; Afzal MS; Saleem M
    Int J Infect Dis; 2020 Sep; 98():166-175. PubMed ID: 32579907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
    Trigueiro-Louro J; Correia V; Figueiredo-Nunes I; Gíria M; Rebelo-de-Andrade H
    Comput Struct Biotechnol J; 2020; 18():2117-2131. PubMed ID: 32913581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.
    Rabbani G; Ahn SN; Kwon H; Ahmad K; Choi I
    Biochem Biophys Rep; 2021 Dec; 28():101170. PubMed ID: 34778573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study.
    S N N; B N R; C P; K S S; Ramakrishnappa T; B T K; S M J; M M; N A; Yallappa ; D DP; T V R; E G; Bagoji M; Chandaragi SS
    Mater Today Proc; 2022; 49():904-912. PubMed ID: 34307057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2.
    Geromichalou EG; Geromichalos GD
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools.
    Nag A; Paul S; Banerjee R; Kundu R
    Comput Biol Med; 2021 Oct; 137():104818. PubMed ID: 34481181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.